Isolated salivary gland extramedullary relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia during blinatumomab treatment

Int J Hematol. 2024 May;119(5):479-480. doi: 10.1007/s12185-024-03756-6. Epub 2024 Mar 16.

Authors

Yugo Kawakami¹, Masaru Imamura², Chihaya Imai^{1

3}

Affiliations

¹ Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Chuou-ku, Niigata, 951-8510, Japan.
² Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Chuou-ku, Niigata, 951-8510, Japan. mimamura@med.niigata-u.ac.jp.
³ Department of Pediatrics, Faculty of Medicine, University of Toyama 2630 Sugitani, Toyama, 930-0194, Japan.

PMID: 38492197
DOI: 10.1007/s12185-024-03756-6

No abstract available

Keywords: Blinatumomab; Extramedullary relapse; Philadelphia chromosome-positive acute lymphoblastic leukemia; Salivary gland.

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Bispecific* / administration & dosage
Antibodies, Bispecific* / adverse effects
Antibodies, Bispecific* / therapeutic use
Antineoplastic Agents / adverse effects
Antineoplastic Agents / therapeutic use
Female
Humans
Male
Philadelphia Chromosome
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
Recurrence
Salivary Glands / pathology

Substances

blinatumomab
Antibodies, Bispecific
Antineoplastic Agents